Nia Impact Advisors, LLC Moderna, Inc. Transaction History

Nia Impact Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $367,468 - $497,803	-3,101 Reduced 10.11%	27,575 $3.35 Million
Q1 2023 May 03, 2023	BUY	$135.66 - $197.02 $48,159 - $69,942	355 Added 1.17%	30,676 $4.71 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $106,542 - $189,036	900 Added 3.06%	30,321 $5.45 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $309,933 - $509,722	-2,625 Reduced 8.19%	29,421 $3.48 Million
Q2 2022 Aug 05, 2022	SELL	$117.13 - $176.59 $325,152 - $490,213	-2,776 Reduced 7.97%	32,046 $4.58 Million
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $927,078 - $1.72 Million	7,331 Added 26.67%	34,822 $6 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $307,115 - $501,173	1,360 Added 5.2%	27,491 $4.41 Million
Q3 2021 Nov 16, 2021	SELL	$221.9 - $484.47 $4.9 Million - $10.7 Million	-22,073 Reduced 45.79%	26,131 $10.1 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $116,009 - $209,837	893 Added 1.89%	48,204 $11.3 Million
Q1 2021 Jun 16, 2021	BUY	$109.18 - $185.98 $478,645 - $815,336	4,384 Added 10.21%	47,311 $6.2 Million
Q4 2020 Jan 25, 2021	BUY	$65.74 - $169.86 $2.82 Million - $7.29 Million	42,927 New	42,927 $4.94 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Nia Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nia Impact Advisors, LLC with notifications on news.